Skip to content
thestock.space

Roopa Industries (BSE: ROOPAIND) had a P/E of 218.3× on 6 Nov 2026, above the industry P/E of 18.2×, and the shares are 31% below their 52-week high. It earns ROCE of 14% and ROE of 0.5%, and sales grew 19% a year over 3 years while net profit fell 61%. Debt is 1.76× equity. It is a small-cap company with a market cap of ₹34 Cr, ranked 68th of 76 Chemicals companies by market cap; the shares fell 14% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹43.99
Day high
₹43.99
Day low
₹42.01
Prev. close
₹42.99
Volume
16

Health check

3 fair · 3 to check
  • ReturnsIn line

    −14.2% over a year, better than 3 of 7 peers.

  • Price tagPricier

    P/E 218.3 vs industry 18.2.

  • GrowthSteady

    Sales +18.7%, profit −60.5% a year over 3 years.

  • ProfitabilityAverage

    ROCE 13.7% vs peer median 10.6%.

  • Balance sheetStretched

    Debt 1.76× equity, interest covered 1.1×, Piotroski 7 of 9.

  • Red flags5 to check

    Return on equity is low at 0.5%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Chemicals

75 listed peers. Screen the industry

Small cap

₹34 Cr, #68 of 76 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹126 Cr · profit ₹0 Cr
Market cap
₹34 Cr
Small cap
P/E
218.3
Industry 18.2
Price to book
1.98
Peers 2.62
Dividend yield
0.00%
ROE
0.5%
Peers 11.7%
ROCE
13.7%
Peers 10.6%
Debt to equity
1.76
Debt ₹31 Cr
EPS (TTM)
₹0.20
OPM (TTM)
6.6%
Net margin 0.1%
Sales growth
−5.0%
Latest quarter vs a year ago
Profit growth
+15.9%
Latest quarter vs a year ago
Price to sales
0.27
EV/EBITDA 7.5

Strengths and risks

Risks to check

  • Return on equity is low at 0.5%.
  • Debt is 1.76× equity.
  • Quarterly sales down 5.0% on a year ago.
  • P/E of 218.3 against an industry P/E of 18.2.
  • 31% below its 52-week high.

No standout strengths in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Roopa Industries

Roopa Industries Limited manufactures, markets, and sells bulk drugs, intermediaries, and fine chemicals in India and internationally. The company offers triphenylphosphine, abacavir sulphate, d-penicillamine, s-octabase, DCC, and DPA 3, etc. It also manufactures and exports glucosamine salts. It serves pharma industry. Roopa Industries Limited was incorporated in 1985 and is based in Hyderabad, India.

Headquarters
Hyderabad
Employees
56
Sector
Basic Materials
ISIN
INE443C01010
Website
investorsatril.com

Price range

52 weeks

₹38.10₹63.40

Today

₹42.01₹43.99
Avg volume (3M)
1.2K
1-year return
minus 14.2%
From 52-week high
minus 31.2%

Peers · Chemicals

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
NAVINFLUORNavin Fluorine International9,010.00plus 1.87%46,25050.842.718.7%34.3%0.2816.5%plus 46.1%
DEEPAKNTRDeepak Nitrite1,533.60minus 0.67%20,91719.722.310.8%18.0%0.27−0.5%minus 11.9%
TATACHEMTata Chemicals607.45minus 1.36%15,475–12.4−3.0%12.2%0.36−4.8%minus 31.0%
DEEPAKFERTDeepak Fertilisers & Petrochemicals Corp.1,155.30minus 0.69%14,59914.811.511.2%17.6%0.762.6%minus 22.7%
RPELRaghav Productivity Enhancers1,780.80plus 0.95%8,178116.0107.1–29.9%0.0223.5%plus 95.4%
GNFCGujarat Narmada Valley Fertilizers and Chemicals451.80minus 1.87%6,6396.35.410.4%14.8%0.01−8.8%minus 7.2%
ACIArchean Chemical Industries416.40minus 1.95%5,14151.323.27.7%20.0%0.28−9.2%minus 34.6%
ROOPAINDRoopa Industries43.65plus 1.54%34218.37.813.7%6.6%1.7618.7%minus 14.2%
Median of 7 peers–−0.69%14,59935.222.310.6%18.0%0.28−0.5%−11.9%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
35.128.733.530.133.3
33.727.131.527.131.8
1.41.623.11.5
4.0%5.7%6.1%10.2%4.6%
0000.10
0.90.80.80.70.9
0.20.20.20.20.2
–––−4.1–
0.40.61.1−1.90.4
22.4%24.6%26.9%23.1%24.5%
0.30.50.8−1.40.3
0.360.590.98-1.800.43

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+18.7%
Profit CAGR 3Y
−60.5%
EPS CAGR 3Y
−57.7%
ROE
0.5%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
76.270.4121128
–minus 7.5%+71.4%+5.6%
71.965.9117124
4.24.54.23.7
5.6%6.5%3.4%2.9%
−0.20.51.74.3
1.42.12.42.8
0.90.90.90.8
−00.10.1−4.3
1.82.22.70.2
25.3%30.1%25.2%50.9%
1.31.520.1
–+12.6%+34.0%minus 95.9%
1.721.932.590.13

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
7.97.97.97.9
6.17.69.69.7
18.925.732.830.6
23.723.526.223.7
56.564.776.572
10.99.78.98.5
1110.1
0000
1.933.40.1
42.75163.263.3
56.564.776.572

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−0.42−6.64.7
−11.12.2−0.5
1.8−2.14.8−7.5
0.410.4−3.3
−1.4−0.8−0.9−0.5
−1.71.2−7.44.1

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you